Vivos Therapeutics, Inc

Contributing Author

Recent Articles by Vivos Therapeutics, Inc

Jun-05	Vivos Therapeutics Announces Binding Agreement for Senior Debt-to-Equity Exchange of Up to $4.5 Million from Streeterville Capital to Support Continued Nasdaq Listing VVOS +24.84% GlobeNewswire
May-20	Vivos Therapeutics Reports First Quarter 2026 Financial Results and Provides Operational Update VVOS GlobeNewswire
Apr-15	Vivos Therapeutics Reports Full Year 2025 Financial Results VVOS -25.85% VVOS +8.89% GlobeNewswire
Apr-15	Vivos Therapeutics Schedules Release of Full Year 2025 Financial Results and Conference Call VVOS +8.89% GlobeNewswire
Apr-07	Vivos Therapeutics Completes Private Placement with Existing Private Equity Investor, New Seneca Partners VVOS -5.34% GlobeNewswire
Mar-26	Vivos Therapeutics Reports that Supported Professional Practices Have Achieved 'In-Network' Status Across Multiple Commercial Health Insurers and Medicare in Key Nevada Market VVOS GlobeNewswire
Mar-17	Recent Study Confirms Fundamental Correlation Between Severity of Obstructive Sleep Apnea and Oral Anatomy VVOS GlobeNewswire
Feb-05	Vivos Therapeutics and SoundHealth Announce Collaboration to Expand Access to SoundHealth's Groundbreaking FDA-Cleared Allergy and Sleep Technologies VVOS GlobeNewswire
Jan-20	Vivos Therapeutics Announces Closing of Exercise of Warrants for $4.64 Million Gross Proceeds VVOS -7.11% VVOS GlobeNewswire
Jan-16	Vivos Therapeutics Announces Exercise of Warrants for $4.64 Million Gross Proceeds VVOS GlobeNewswire
Dec-16	Vivos Therapeutics Announces Grand Opening of Affiliated Sleep Center Near Detroit, Michigan VVOS GlobeNewswire
Dec-15	Vivos Therapeutics to Participate in Online Fireside Chat with Water Tower Research on December 16, 2025, at 11 am EST VVOS GlobeNewswire
Nov-19	Vivos Therapeutics Reports Significant Revenue Growth During the Third Quarter 2025 VVOS -10.17% VVOS GlobeNewswire
Nov-19	Vivos Therapeutics Schedules Release of Third Quarter 2025 Financial Results and Conference Call VVOS GlobeNewswire
Sep-30	Vivos Therapeutics Releases Additional Clinical Data Showing Marked Improvement in Pediatric ADHD from Use of Vivos DNA Device VVOS GlobeNewswire
Sep-17	Vivos Therapeutics Announces Landmark Clinical Trial Results in Pediatric Obstructive Sleep Apnea Treatment VVOS GlobeNewswire
Aug-19	Vivos Therapeutics Reports Second Quarter 2025 Financial Results and Provides Operational Update VVOS GlobeNewswire
Aug-19	Vivos Therapeutics Schedules Release of Second Quarter 2025 Financial Results and Conference Call VVOS GlobeNewswire
Jul-30	Vivos Therapeutics Adds to Management Team to Support Expansion and Growth VVOS GlobeNewswire
Jul-01	Vivos Therapeutics Receives Medicare Approval for VidaSleep Oral Appliance VVOS +22.47% GlobeNewswire
Jun-26	New Clinical Trial Data Published Showing Positive Results from Use of Vivos Technology to Treat Obstructive Sleep Apnea in Children VVOS +10.49% GlobeNewswire
Jun-11	Vivos Therapeutics Completes Acquisition of The Sleep Center of Nevada VVOS +5.21% GlobeNewswire
May-15	Vivos Therapeutics Reports First Quarter 2025 Financial Results and Provides Operational Update VVOS -16.99% VVOS GlobeNewswire
May-14	Vivos Therapeutics Schedules Release of First Quarter 2025 Financial Results and Conference Call VVOS GlobeNewswire

Vivos Therapeutics, Inc

Recent Articles by Vivos Therapeutics, Inc

Upgrade your Finviz experience